Chief Scientific Officer · MoonLake Immunotherapeutics (MLTX)

Kristian Reich

A named executive officer of MoonLake Immunotherapeutics in every fiscal year CompBrief holds from FY2023 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$4,795,493

FY2024: $1,302,939

Compensation figures as of the proxy filed April 21, 2026 (DEF 14A).

Kristian Reich compensation by year

MoonLake Immunotherapeutics Summary Compensation Table · all 3 fiscal years held
In US dollars, as MoonLake Immunotherapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023FY2024FY2025
Salary$586,333$698,245$762,386
Bonus$589,819$574,254$0
Stock awards$0$0$0
Option awards$0$0$4,000,021
Non-equity incentive$0$0$0
Pension and deferred compensation$0$0$0
All other$54,752$30,440$33,086
Total$1,230,904$1,302,939$4,795,493

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: MoonLake Immunotherapeutics DEF 14A filed April 21, 2026, accession 0001140361-26-015916, and prior-year filings. Open the filing on EDGAR.

$1.2M
$1.3M
$4.8M
FY23
FY24
FY25
SalaryBonusOption awardsAll other

MoonLake Immunotherapeutics’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Jorge Santos da SilvaChief Executive Officer; Interim Chair of the Board$4,943,209
Kristian Reich · this pageChief Scientific Officer$4,795,493
Matthias BodenstedtChief Financial Officer$4,692,576

The full MoonLake Immunotherapeutics compensation record

free company brief

This page is one person within MoonLake Immunotherapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order MoonLake Immunotherapeutics's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are MoonLake Immunotherapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy